Presented By
Alberta Impact is proud to work with Health Cities to bring you this ten episode series highlighting Alberta based health innovators, collaborations and partnerships that are working to mold the "Future of Health".
Entos Pharmaceuticals on possible vaccine for COVID-19 through Fusogenix
After the announcement from Entos Pharmaceutical about their Fusogenix DNA vaccine development against COVID19, Sars, Mers and other coronavirus; our partners from Health City (CEO Reg Joseph) along with Dr. John Lewis (CEO of Entos Pharmaceutical) and Arun - head scientistl had a in-depth conversation.
Connect with Entos Pharmaceutical: https://www.entospharma.com/
Connect with Dr. John Lewis: https://www.linkedin.com/in/john-lewis
Connect with Reg Joseph: https://www.linkedin.com/in/reg-joseph